FDA approves oritavancin for acute bacterial skin and skin structure infections Aug. 7, 2014 No Comments
Conditional marketing authorization in E.U. for Translarna in Duchenne muscular dystrophy Aug. 6, 2014 No Comments
Kitasato Daiichi Sankyo Vaccine obtains pertussis-diphtheria-tetanus-polio vaccine licenses July 7, 2014 No Comments
RSS